BSEResult1d ago · 14 Aug 2026, 07:26 pm
Quarterly Results June 30, 2026
Natural Biocon (India) Ltd · 543207
✦ AI SummaryResults
Natural Biocon (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 8785 lakhs and profit before tax at Rs. 16 lakhs. The company has also approved the appointment of new statutory auditors and the resignation of the previous auditors.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natural Biocon (India) Ltd - 543207 - Quarterly Results June 30, 2026
Attachments (1)
📄pdf
Download →
dfe98300-fa74-40d1-a6d5-fe74b9ebb03f.pdf
View document text
BNIAOTUCROANL
miveo & www.naturalbiocon.com
Regd. Office :
o soo o BN info@naturalbiocon.com @) A-1007.Sankalp iconic Tower.
A g= Opp, Vikram Nagar,Iscon Temple Cross Road,
S.G.Highway, Ahmedabad 380054,Gujarat,India
oSt No - 2anAacNGss1KizD || GIN:L24299GI1992PLC018210
August 14, 2026
To, To,
The General Manager Corporation The Secretary
Relationship Department BSE Limited The Calcutta Stock Exchange Ltd.
P.] Towers, Dalal Street 7, Lyons Range
Mumbai - 400001 Kolkata - 700 001
Script Code: 543207 Scrip Code: 24151
Dear Sir/Madam,
Sub: Outcome of the meeting of the Board of Directors held on Friday, August 14, 2026.
Ref: Regulation 30 & 33 of the Securities and Exchange Board of India (Listing Obligation and
Disclosure Requirement) Regulation, 2015.
‘With reference to above subject and in compliance with Regulation 30 and 33 of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the
outcome of the Meeting of the Board of Directors held on today i.e., Friday, August 14, 2026 at 06:30 p.m. and
concluded on 07:10 p.m. inter alia considered and approved the following:
1) Un-Audited Financial Results (UFR) for the quarter ended June 30, 2026, along with the Statutory
Auditors’ Limited Review Report.
2) Considered and approved the appointment of M/s Nirav S Shah & Co as the Statutory Auditors
oft he Company with effect from 1% August 2026.
3) Approved the resignation of M/s Mayur Shah & Associates as the Statutory Auditors of the
Company with effect from 31° July 2026.
4) Reviewed the other businesses of the company.
Please take the same on record.
BNIAOTUCROANL
@ www.naturalbiocon.com
Regd. Office :
©79 46005570 B info@naturalbiocon.com ) A-1007.Sankalp iconic Tower.
Opp, Vikram Nagar,Iscon Temple Cross Road,
S.G.Highway, Ahmedabad 380054,Gujarat,India
oSt No - 2anAacNGss1KizD || GIN:L24299GI1992PLC018210
Thanking You
Yours faithfully,
For Natural Biocon (India) Limited
Pom D (P /"'\(//'%>
Arunkumar Prajapati
Managing Director
DIN: 08281232
Encl. As Above
NATURAL BIOCON (INDIA) LIMITED
N - 124209GJ1992PLC018210
Reg off: 1007, Sankalp Iconic, Opp. Vikram Nagar, Iscon Temple Cross Road, S. G. Highway,Ahmedabad, Ahmedabad, Gujarat, India, 380054
E-Mail: naturalbiocon@gmail.com
STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE
QUARTER AND YEAR ENDED JUNE 30, 2026
(Amtin Rs. In Lakhs)
‘Quarter ended Vear Ended
3006.2026 31032026 30062025 3103.2026 31032025
SLNO PARTICULARS (Unaudited) (Audited) (Audited) (Audited) (Audited)
i [Revenue from Operations B 8785 16657 25441 83451
[T [OtherTcome B 012 - 012 -
@ [Total Income(i-1 - 8797 16657 25454 834.81
[V [EXPENSES
[Cost of materials consumed - - - - -
[Purchases of Stock i wade - 20089 20089 739.96
[Changes i Taventones of Tiished g00ds, Stock-i-uade
Jand work in progress 7053 (5388) 1665 ©56)
[Exployee benefits expense B 1118 225 1747 3067
[Finance Costs B - - - -
[Depreciation and amortization expenses 010 009 006 034 006
[Other expenses 106 1551 339 519 5872
[Total Expenses 116 9731 15271 25854 828,85
[V [Profit/os) before exceptional items and tax(-IV) .16) ©39) 1386 @00) 596
[V [Exceptional tems - - -
VI [Profit/osy) before tax(v-vD) 16) ©39) 1386 @00) 596
[VIT[Tax Expense
(D) Curent Tax - - - - 150
[ Deferred Tax B B B B -
[Profit/(Loss) for the period from continuing operatons(
x vovim 16) ©34) 1386 “00) 446
[X[Profit(Loss) fom discontinued operations - - - - -
[XI [T ax Expense of discontinued operations B B B B B
Profit(loss)from Discontmed operations( After Ta) (-
XTI [Profit/oss) for the period (X-XID) 16) ©39) 1386 @00) 446
X1V [Other Comprehensive Tncome - - - -
Total Comprehensive Income for fhe period (XIFFXIV)
[ Comprising Profit (Loss) and Other Comprehensive
[xv_|Income for the period] 16) ©34) 1386 “00) 446
[xxv1 _|Paid up Equity Share Capital (Face value of Rs 10/- each) 2578.28 257828 2578.28 257828 257828
[Reserves exchuding revaluafion reserves as per balance sheef
Vi |of previous years - - - - -
Eamings per Equity Share (for contiming operaBom(Not
[xvi|anmaised)
(1 Basic (0.00) ©00%) 005 ©0) 002
[ Diuted (0.00) (0.0%) 005 ©00) 002
3V _|Eamings per Equity Share (for discontimed operation)
(D) Basic - - - - -
| Diuted - - - - -
Eamings per Equity Share (for contiming & disconimed
[ |operaton)
(1) Basic (0.00) 0.0%) 005 ) [
| Dituted (0.00) (0.0%) 005 ©00) [
1 The above Standalone audited financial results of the Company for the quarter ended Juae 30th have been reviewed and have been approved and taken on fecord by the Board of Directors i its
me eting held on 14th August, 2026.
2. The Company has single reportable segment as defined in Indian Accounting Standard 108 and therefore segment reporting is not applicable for the company.
3 The above Standalone Financial results have been are prepaed as per applicable IND Accounting standards notified by Ministry of Corporate Affairs.
4 Figures of the previous period have been regrouped wherever necessary to the current year classification.
5 EPS is calculated in accordance with IND AS issued by ICAL
For Natural Biocon (India) Limited
Arunkumar Prajapati
Managing Director
[Piace: Abmedabad
[Date: 14/08/2026 DIN: 08281232
Nirav S. Shah & Co. PN Nirav Shah
Chartered Accountants B.com, LLB, FCA
Office Add : 401, Abhishree Avenue, Opp. Hanuman Temple, Besides Shakti Electronics,
Nehrunagar-Ambawadi, Ahmedabad - 380 015.
M. No. 98256 09734 Email : incometax@caniravshah.com
BOARD OF DIRECTORS,
NATURAL BIOCON (INDIA) LIMITED
AHMEDABAD
LIMITED REVIEW REPORT
"We have reviewed the accompanying statement of unaudited financial results of M/s.
NATURAL BIOCON (INDIA) LIMITED for the period ended 30.06.2026. This statement is
the responsibility of the Company’s management and has been approved by the Board of
Directors.
A review of interim financial information consists principally of applying analytical
procedures for financial data and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in accordance
with the generally accepted auditing standards, the objective of which is the expression of an
opinion regarding the financial statements taken as a whole. Accordingly, we do not express
such an opinion.
Based on our review conducted as above, nothing has come to our notice that causes us to
believe that the accompanying statement of unaudited financial results prepared in
accordance with Accounting Standards and other recognized accounting practices and
policies has not disclosed the information required to be disclosed in terms of Regulation 33
of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including
the manner in which it is to be disclosed, or that it contains any material misstatement"
Date: 14.08.2026 Name of CA : Nirav Shah g
Place: Ahmedabad FirmName : Nirav S. Shah
Designation : Proprietor
Membership No: 133345
FRN : o 130244w
UDIN : 26133345TUMQFU3766